Norwalk virus shedding after experimental human infection.

Norovirus gastroenteritis. N Engl J Med (2009) 7.66

Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78

Adjuvanted intranasal Norwalk virus-like particle vaccine elicits antibodies and antibody-secreting cells that express homing receptors for mucosal and peripheral lymphoid tissues. J Infect Dis (2010) 2.64

Malaria medicines: a glass half full? Nat Rev Drug Discov (2015) 2.53

Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50

Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21

Diagnosing norovirus-associated infectious intestinal disease using viral load. BMC Infect Dis (2009) 2.09

Chimpanzees as an animal model for human norovirus infection and vaccine development. Proc Natl Acad Sci U S A (2010) 1.96

Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection. Science (2014) 1.92

Noroviruses: The leading cause of gastroenteritis worldwide. Discov Med (2010) 1.73

Epidemiology of foodborne norovirus outbreaks, United States, 2001-2008. Emerg Infect Dis (2012) 1.69

Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog (2008) 1.69

Pathogenesis of noroviruses, emerging RNA viruses. Viruses (2010) 1.67

Burden of norovirus in healthcare facilities and strategies for outbreak control. J Hosp Infect (2015) 1.55

Herd immunity to GII.4 noroviruses is supported by outbreak patient sera. J Virol (2009) 1.51

Multicenter evaluation of the BioFire FilmArray gastrointestinal panel for etiologic diagnosis of infectious gastroenteritis. J Clin Microbiol (2015) 1.50

Replication of human noroviruses in stem cell-derived human enteroids. Science (2016) 1.44

Type I Interferon Receptor Deficiency in Dendritic Cells Facilitates Systemic Murine Norovirus Persistence Despite Enhanced Adaptive Immunity. PLoS Pathog (2016) 1.40

Norwalk virus does not replicate in human macrophages or dendritic cells derived from the peripheral blood of susceptible humans. Virology (2010) 1.40

Noroviruses - State of the Art. Food Environ Virol (2010) 1.39

Duration of immunity to norovirus gastroenteritis. Emerg Infect Dis (2013) 1.38

A single-amino-acid change in murine norovirus NS1/2 is sufficient for colonic tropism and persistence. J Virol (2012) 1.37

Bacterial and viral pathogens in live oysters: 2007 United States market survey. Appl Environ Microbiol (2010) 1.35

Protruding domain of capsid protein is necessary and sufficient to determine murine norovirus replication and pathogenesis in vivo. J Virol (2012) 1.34

Randomized, double-blinded clinical trial for human norovirus inactivation in oysters by high hydrostatic pressure processing. Appl Environ Microbiol (2011) 1.26

Lack of norovirus replication and histo-blood group antigen expression in 3-dimensional intestinal epithelial cells. Emerg Infect Dis (2013) 1.23

Serological responses to experimental Norwalk virus infection measured using a quantitative duplex time-resolved fluorescence immunoassay. Clin Vaccine Immunol (2011) 1.20

Influence of novel norovirus GII.4 variants on gastroenteritis outbreak dynamics in Alberta and the Northern Territories, Canada between 2000 and 2008. PLoS One (2010) 1.20

Comprehensive analysis of a norovirus-associated gastroenteritis outbreak, from the environment to the consumer. J Clin Microbiol (2010) 1.20

Astrovirus MLB1 is not associated with diarrhea in a cohort of Indian children. PLoS One (2011) 1.20

Characterization of emerging GII.g/GII.12 noroviruses from a gastroenteritis outbreak in the United States in 2010. J Clin Microbiol (2011) 1.18

Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities. Gastroenterology (2014) 1.16

Challenges of culturing human norovirus in three-dimensional organoid intestinal cell culture models. PLoS One (2013) 1.15

Association between stool enteropathogen quantity and disease in Tanzanian children using TaqMan array cards: a nested case-control study. Am J Trop Med Hyg (2013) 1.15

Effectiveness of liquid soap and hand sanitizer against Norwalk virus on contaminated hands. Appl Environ Microbiol (2009) 1.14

Chronic diarrhea associated with persistent norovirus excretion in patients with chronic lymphocytic leukemia: report of two cases. BMC Infect Dis (2011) 1.11

Diagnostic accuracy and analytical sensitivity of IDEIA Norovirus assay for routine screening of human norovirus. J Clin Microbiol (2010) 1.11

Serum hemagglutination inhibition activity correlates with protection from gastroenteritis in persons infected with Norwalk virus. Clin Vaccine Immunol (2011) 1.10

Critical role for interferon regulatory factor 3 (IRF-3) and IRF-7 in type I interferon-mediated control of murine norovirus replication. J Virol (2012) 1.09

Factors that explain excretion of enteric pathogens by persons without diarrhea. Clin Infect Dis (2012) 1.09

Noroviruses: the perfect human pathogens? J Infect Dis (2012) 1.09

New real-time PCR detects prolonged norovirus excretion in highly immunosuppressed patients and children. J Clin Microbiol (2009) 1.06

The viral polymerase inhibitor 2'-C-methylcytidine inhibits Norwalk virus replication and protects against norovirus-induced diarrhea and mortality in a mouse model. J Virol (2013) 1.05

Distribution in tissue and seasonal variation of norovirus genogroup I and II ligands in oysters. Appl Environ Microbiol (2010) 1.05

Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses. J Virol (2013) 1.05

Infection control for norovirus. Clin Microbiol Infect (2014) 1.02

Failure of propagation of human norovirus in intestinal epithelial cells with microvilli grown in three-dimensional cultures. Arch Virol (2013) 1.01

Foodborne norovirus outbreak: the role of an asymptomatic food handler. BMC Infect Dis (2010) 1.01

Human norovirus transmission and evolution in a changing world. Nat Rev Microbiol (2016) 1.01

Within-host evolution results in antigenically distinct GII.4 noroviruses. J Virol (2014) 0.99

Development of Norwalk virus-specific monoclonal antibodies with therapeutic potential for the treatment of Norwalk virus gastroenteritis. J Virol (2013) 0.99

Economic value of norovirus outbreak control measures in healthcare settings. Clin Microbiol Infect (2010) 0.98

Model systems for the study of human norovirus Biology. Future Virol (2009) 0.97

Antibody responses to norovirus genogroup GI.1 and GII.4 proteases in volunteers administered Norwalk virus. Clin Vaccine Immunol (2012) 0.97

Characterization of norovirus-associated traveler's diarrhea. Clin Infect Dis (2010) 0.96

Identification of human single-chain antibodies with broad reactivity for noroviruses. Protein Eng Des Sel (2014) 0.95

Pattern of circulation of norovirus GII strains during natural infection. J Clin Microbiol (2014) 0.93

An outbreak of norovirus gastroenteritis in an Austrian hospital, winter 2006-2007. Wien Klin Wochenschr (2009) 0.92

Epidemiology of foodborne Norovirus outbreak in Incheon, Korea. J Korean Med Sci (2010) 0.92

Median infectious dose of human norovirus GII.4 in gnotobiotic pigs is decreased by simvastatin treatment and increased by age. J Gen Virol (2013) 0.91

Norovirus genotypes present in oysters and in effluent from a wastewater treatment plant during the seasonal peak of infections in Ireland in 2010. Appl Environ Microbiol (2013) 0.91

Human norovirus infection of caco-2 cells grown as a three-dimensional tissue structure. J Water Health (2011) 0.90

Norovirus contamination on French marketed oysters. Int J Food Microbiol (2013) 0.89

Norovirus and Sapovirus Epidemiology and Strain Characteristics among Navajo and Apache Infants. PLoS One (2017) 0.87

Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples. J Clin Microbiol (2013) 0.87

A nosocomial outbreak of norovirus infection masquerading as clostridium difficile infection. Clin Infect Dis (2009) 0.87

Calicivirus removal in a membrane bioreactor wastewater treatment plant. Appl Environ Microbiol (2011) 0.87

The Prevalence of Norovirus in returning international travelers with diarrhea. BMC Infect Dis (2010) 0.87

Sources of airborne microorganisms in the built environment. Microbiome (2015) 0.87

Norovirus immunology: Of mice and mechanisms. Eur J Immunol (2015) 0.85

Of gastro and the gold standard: evaluation and policy implications of norovirus test performance for outbreak detection. J Transl Med (2009) 0.85

Norovirus Epidemiology in Africa: A Review. PLoS One (2016) 0.84

Experimental human infection with Norwalk virus elicits a surrogate neutralizing antibody response with cross-genogroup activity. Clin Vaccine Immunol (2014) 0.84

Application of a receptor-binding capture quantitative reverse transcription-PCR assay to concentrate human norovirus from sewage and to study the distribution and stability of the virus. Appl Environ Microbiol (2011) 0.83

Lifting the lid on toilet plume aerosol: a literature review with suggestions for future research. Am J Infect Control (2012) 0.83

Inactivation of murine norovirus on a range of copper alloy surfaces is accompanied by loss of capsid integrity. Appl Environ Microbiol (2014) 0.83

Infectious diarrhea: when to test and when to treat. CMAJ (2010) 0.83

Environmental transmission of human noroviruses in shellfish waters. Appl Environ Microbiol (2014) 0.82

The application of new molecular methods in the investigation of a waterborne outbreak of norovirus in Denmark, 2012. PLoS One (2014) 0.82

Noroviruses as a Cause of Diarrhea in Immunocompromised Pediatric Hematopoietic Stem Cell and Solid Organ Transplant Recipients. Am J Transplant (2015) 0.81

Linking time-varying symptomatology and intensity of infectiousness to patterns of norovirus transmission. PLoS One (2013) 0.81

Sanitizer efficacy against murine norovirus, a surrogate for human norovirus, on stainless steel surfaces when using three application methods. Appl Environ Microbiol (2012) 0.80

An outbreak of acute norovirus gastroenteritis in a boarding school in Shanghai: a retrospective cohort study. BMC Public Health (2014) 0.80

The South to north variation of norovirus epidemics from 2006-07 to 2008-09 in Japan. PLoS One (2013) 0.80

A next generation sequencing-based method to study the intra-host genetic diversity of norovirus in patients with acute and chronic infection. BMC Genomics (2016) 0.80

The potential for a controlled human infection platform in Singapore. Singapore Med J (2014) 0.80

Bioluminescent enzyme immunoassay for the detection of norovirus capsid antigen. Clin Vaccine Immunol (2012) 0.79

DNA microarray for detection of gastrointestinal viruses. J Clin Microbiol (2014) 0.79

Specimen collection and confirmation of norovirus outbreaks. Emerg Infect Dis (2011) 0.79

Aerosol Generation by Modern Flush Toilets. Aerosol Sci Technol (2015) 0.79

Epidemiology and Genetic Characterization of Noroviruses among Adults in an Endemic Setting, Peruvian Amazon Basin, 2004-2011. PLoS One (2015) 0.79

Age-Specific Incidence Rates for Norovirus in the Community and Presenting to Primary Healthcare Facilities in the United Kingdom. J Infect Dis (2016) 0.79

Effects of Abiotic and Biotic Stresses on the Internalization and Dissemination of Human Norovirus Surrogates in Growing Romaine Lettuce. Appl Environ Microbiol (2015) 0.78

Pediatric norovirus infection. Eur J Clin Microbiol Infect Dis (2013) 0.78

Aerosolization of a Human Norovirus Surrogate, Bacteriophage MS2, during Simulated Vomiting. PLoS One (2015) 0.78

Evidence-Based interventions of Norovirus outbreaks in China. BMC Public Health (2016) 0.78

Inactivation Kinetics and Mechanism of a Human Norovirus Surrogate on Stainless Steel Coupons via Chlorine Dioxide Gas. Appl Environ Microbiol (2015) 0.77

Deciphering the Diversities of Astroviruses and Noroviruses in Wastewater Treatment Plant Effluents by a High-Throughput Sequencing Method. Appl Environ Microbiol (2015) 0.77

The spread and control of norovirus outbreaks among hospitals in a region: a simulation model. Open Forum Infect Dis (2014) 0.76

Norovirus in symptomatic and asymptomatic individuals: cytokines and viral shedding. Clin Exp Immunol (2016) 0.76

Food-related illness and death in the United States. Emerg Infect Dis (1999) 39.22

Human susceptibility and resistance to Norwalk virus infection. Nat Med (2003) 7.07

Clinical immunity in acute gastroenteritis caused by Norwalk agent. N Engl J Med (1977) 4.80

Norwalk virus infection of volunteers: new insights based on improved assays. J Infect Dis (1994) 4.37

Transmission of acute infectious nonbacterial gastroenteritis to volunteers by oral administration of stool filtrates. J Infect Dis (1971) 3.88

Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996). Eur J Clin Microbiol Infect Dis (2007) 3.50

Diagnosis of noncultivatable gastroenteritis viruses, the human caliciviruses. Clin Microbiol Rev (2001) 3.28

Natural history of human calicivirus infection: a prospective cohort study. Clin Infect Dis (2002) 3.24

Pattern of shedding of the Norwalk particle in stools during experimentally induced gastroenteritis in volunteers as determined by immune electron microscopy. J Infect Dis (1975) 2.74

Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J Infect Dis (1990) 2.63

The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am (2006) 2.49

Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34

Fecal viral load and norovirus-associated gastroenteritis. Emerg Infect Dis (2006) 2.20

Norovirus infections in symptomatic and asymptomatic food handlers in Japan. J Clin Microbiol (2007) 2.13

In vitro cell culture infectivity assay for human noroviruses. Emerg Infect Dis (2007) 2.07

A foodborne outbreak of gastroenteritis associated with Norwalk-like viruses: first molecular traceback to deli sandwiches contaminated during preparation. J Infect Dis (2000) 1.81

Use of heat release and an internal RNA standard control in reverse transcription-PCR detection of Norwalk virus from stool samples. J Clin Microbiol (1997) 1.77

Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A (2005) 1.56

Prolonged norovirus shedding in infants <or=6 months of age with gastroenteritis. Pediatr Infect Dis J (2007) 1.50

Fecal viral concentration and diarrhea in norovirus gastroenteritis. Emerg Infect Dis (2007) 1.25

Investigation of norovirus replication in a human cell line. Arch Virol (2006) 1.24

Development of an immunomagnetic capture reverse transcription-PCR assay for the detection of Norwalk virus. J Virol Methods (2000) 1.24

Outbreak of SRSV gastroenteritis at an international conference traced to food handled by a post-symptomatic caterer. Epidemiol Infect (1993) 1.14

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62

Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92

Norovirus gastroenteritis. N Engl J Med (2009) 7.66

Norwalk virus infection and disease is associated with ABO histo-blood group type. J Infect Dis (2002) 5.09

Laboratory efforts to cultivate noroviruses. J Gen Virol (2004) 4.41

Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87

Norovirus vaccine against experimental human Norwalk Virus illness. N Engl J Med (2011) 3.78

Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol (2005) 3.34

Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production. Gastroenterology (2002) 3.27

Norwalk virus-like particle hemagglutination by binding to h histo-blood group antigens. J Virol (2003) 3.15

The peopling of the Pacific from a bacterial perspective. Science (2009) 3.14

Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score. J Clin Gastroenterol (2012) 2.99

Gastroesophageal reflux among different racial groups in the United States. Gastroenterology (2004) 2.87

Norovirus disease: changing epidemiology and host susceptibility factors. Trends Microbiol (2004) 2.83

Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol (2008) 2.77

Age at acquisition of Helicobacter pylori infection: a follow-up study from infancy to adulthood. Lancet (2002) 2.71

Helicobacter pylori in North and South America before Columbus. FEBS Lett (2002) 2.57

Visible small-intestinal mucosal injury in chronic NSAID users. Clin Gastroenterol Hepatol (2005) 2.54

Atomic resolution structural characterization of recognition of histo-blood group antigens by Norwalk virus. Proc Natl Acad Sci U S A (2008) 2.54

Rotavirus antigenaemia and viraemia: a common event? Lancet (2003) 2.51

Determination of the 50% human infectious dose for Norwalk virus. J Infect Dis (2013) 2.50

The epidemiologic and clinical importance of norovirus infection. Gastroenterol Clin North Am (2006) 2.49

A report card to grade Helicobacter pylori therapy. Helicobacter (2007) 2.41

The 3' end of Norwalk virus mRNA contains determinants that regulate the expression and stability of the viral capsid protein VP1: a novel function for the VP2 protein. J Virol (2003) 2.38

Structural requirements for the assembly of Norwalk virus-like particles. J Virol (2002) 2.38

Norwalk virus infection associates with secretor status genotyped from sera. J Med Virol (2005) 2.34

Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology (2002) 2.32

Serological correlate of protection against norovirus-induced gastroenteritis. J Infect Dis (2010) 2.21

Sequential and concomitant therapy with four drugs is equally effective for eradication of H pylori infection. Clin Gastroenterol Hepatol (2009) 2.15

X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity. Proc Natl Acad Sci U S A (2006) 2.09

Rotaviruses: from pathogenesis to vaccination. Gastroenterology (2009) 2.05

Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med (2011) 2.04

Comparing the Blatchford and pre-endoscopic Rockall score in predicting the need for endoscopic therapy in patients with upper GI hemorrhage. Gastrointest Endosc (2010) 2.04

Duodenal ulcer promoting gene of Helicobacter pylori. Gastroenterology (2005) 2.03

Meta-analysis: four-drug, three-antibiotic, non-bismuth-containing "concomitant therapy" versus triple therapy for Helicobacter pylori eradication. Helicobacter (2009) 2.02

Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol (2011) 1.98

Magnet ingestions in children presenting to US emergency departments, 2002-2011. J Pediatr Gastroenterol Nutr (2013) 1.98

Gastritis staging in clinical practice: the OLGA staging system. Gut (2006) 1.90

Complications of pediatric EGD: a 4-year experience in PEDS-CORI. Gastrointest Endosc (2007) 1.89

Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin Immunol (2003) 1.89

Neonatal infection with G10P[11] rotavirus did not confer protection against subsequent rotavirus infection in a community cohort in Vellore, South India. J Infect Dis (2007) 1.83

Inter- and intragenus structural variations in caliciviruses and their functional implications. J Virol (2004) 1.79

Risk factors for immediate and delayed bleeding associated with endoscopic submucosal dissection of gastric neoplastic lesions. Scand J Gastroenterol (2009) 1.75

NSAIDs, Helicobacter pylori, and Pandora's Box. N Engl J Med (2002) 1.75

Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter (2011) 1.73

Discrimination between cases of duodenal ulcer and gastritis on the basis of putative virulence factors of Helicobacter pylori. J Clin Microbiol (2002) 1.72

Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity. J Virol (2005) 1.71

Patterns of gastric atrophy in intestinal type gastric carcinoma. Cancer (2002) 1.69

Biliary stenting in the management of large or multiple common bile duct stones. Gastrointest Endosc (2010) 1.68

Norwalk virus RNA is infectious in mammalian cells. J Virol (2007) 1.66

Cell attachment protein VP8* of a human rotavirus specifically interacts with A-type histo-blood group antigen. Nature (2012) 1.65

Norwalk virus-specific binding to oyster digestive tissues. Emerg Infect Dis (2006) 1.63

Management of gastric polyps: a pathology-based guide for gastroenterologists. Nat Rev Gastroenterol Hepatol (2009) 1.62

The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. Gastrointest Endosc (2006) 1.60

Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection. Gastroenterology (2004) 1.59

Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation. Gastroenterology (2002) 1.58

Iron deficiency and Helicobacter pylori infection in the United States. Am J Epidemiol (2005) 1.57

Effects of sirolimus on plasma lipids, lipoprotein levels, and fatty acid metabolism in renal transplant patients. J Lipid Res (2002) 1.56

Replication and packaging of Norwalk virus RNA in cultured mammalian cells. Proc Natl Acad Sci U S A (2005) 1.56

Endoscopic demonstration of transient small bowel intussusception in a patient with adult celiac disease. Gastrointest Endosc (2003) 1.55

Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid. J Virol (2005) 1.53

Structural analysis of histo-blood group antigen binding specificity in a norovirus GII.4 epidemic variant: implications for epochal evolution. J Virol (2011) 1.53

Comparative study of the epidemiology of rotavirus in children from a community-based birth cohort and a hospital in South India. J Clin Microbiol (2006) 1.51

Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol (2012) 1.51

Rising incidence of inflammatory bowel disease among children: a 12-year study. J Pediatr Gastroenterol Nutr (2010) 1.51

Epidemiology of human noroviruses and updates on vaccine development. Curr Opin Gastroenterol (2014) 1.49

Rotavirus architecture at subnanometer resolution. J Virol (2008) 1.48

Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog (2008) 1.48

Helicobacter pylori eradication and change in markers of iron stores among non-iron-deficient children in El Paso, Texas: an etiologic intervention study. J Pediatr Gastroenterol Nutr (2011) 1.47

Helicobacter pylori virulence factors: facts and fantasies. Curr Opin Gastroenterol (2005) 1.44

Seroepidemiology of norovirus-associated travelers' diarrhea. J Travel Med (2014) 1.43

Rotavirus viremia and extraintestinal viral infection in the neonatal rat model. J Virol (2006) 1.43

Vaccine-acquired rotavirus in infants with severe combined immunodeficiency. N Engl J Med (2010) 1.43

Etest for metronidazole susceptibility in H. pylori: use of the wrong standard may have led to the wrong conclusion. Am J Gastroenterol (2004) 1.43

Effect of the carbonic anhydrase inhibitor, acetazolamide, on Helicobacter pylori infection in vivo: a pilot study. Helicobacter (2005) 1.42

Initial interaction of rotavirus strains with N-acetylneuraminic (sialic) acid residues on the cell surface correlates with VP4 genotype, not species of origin. J Virol (2002) 1.42

Rotavirus antigenemia in children is associated with viremia. PLoS Med (2007) 1.42

Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41